The objective of the Biostatistics Resource is to be strategically involved in the design, implementation, and analysis of clinical and scientific data generated by CCSG program members. This includes the articulation of study objectives, characterization of hypotheses, the derivation of appropriate designs and models to cost-effectively achieve a study's objectives, the assurance that modern and appropriate statistical and mathematical data analytic methods are used, monitoring interim and final analyses, and assisting in the writing of abstracts and manuscripts. The expertise provided by the staff ensures that the yield of useful information from the scientific studies conducted at Roswell Park Cancer Institute is maximized while the costs are minimized. Concepts and tools from the disciplines of statistics, mathematics, engineering science, and computer science are used to accomplish these goals. Most projects require the use of standard and commercially available tools. Occasionally, a particular laboratory or clinical problem requires an innovative solution for which the Resource develops the novel methodology. The Biostatistics Resource fosters intra-, inter- and extra-programmatic creativity and productivity, and provides objective and critical feedback to RPCI researchers as they seek answers to complex problems, when the numbers of experimental subjects must be kept small, when ethical concerns are critical, and when the goals of a research project demand the integrated participation of multiple scientific groups. With the appointment of James Kepner, PhD, a distinguished biostatistician, as Director in August 2002, the Resource is being restructured with input from the Resource's Advisory Committee and the CCSG Steering Committee, of which Dr. Kepner is a member. Some of the ways in which the Resource's expanded and enhanced capabilities are being made known to program leaders are through referrals, by the Scientific Review Committee's insistence that protocols and grant applications have input from a biostatistician, formal seminars given by Resource staff, and Dr. Kepner's presentations at program meetings.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-31
Application #
7417846
Study Section
Project Start
2007-05-01
Project End
2008-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
31
Fiscal Year
2007
Total Cost
$256,286
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Gabriel, Emmanuel; Attwood, Kristopher; Al-Sukhni, Eisar et al. (2018) Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol 9:96-110
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :
Zhang, Dingxiao; Tang, Dean G; Rycaj, Kiera (2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Semin Cancer Biol 52:94-106
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Leonova, Katerina; Safina, Alfiya; Nesher, Elimelech et al. (2018) TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells. Elife 7:

Showing the most recent 10 out of 1555 publications